CD4 and tuberculosis: INSPIRING (NCT02178592) is a Phase 3b, non‐comparative, active control, randomized, open‐label study in HIV‐1 infected ART‐naïve adults (CD4 +  350 cells/μl) with drug‐sensitive TB.